Your browser doesn't support javascript.
loading
Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?
Saumell, Sílvia; Solé, Francesc; Arenillas, Leonor; Montoro, Julia; Valcárcel, David; Pedro, Carme; Sanzo, Carmen; Luño, Elisa; Giménez, Teresa; Arnan, Montserrat; Pomares, Helena; De Paz, Raquel; Arrizabalaga, Beatriz; Jerez, Andrés; Martínez, Ana B; Sánchez-Castro, Judith; Rodríguez-Gambarte, Juan D; Raya, José M; Ríos, Eduardo; Rodríguez-Rivera, María; Espinet, Blanca; Florensa, Lourdes.
Afiliación
  • Saumell S; Laboratori de Citologia Hematològica i Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain; GRETNHE, Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Department of Medicine, Medicine Faculty, Universitat Autònoma de Barcelona,
  • Solé F; Institut de Recerca Contra la Leucèmia Josep Carreras, Cytogenetics Platform, Badalona, Spain.
  • Arenillas L; Laboratori de Citologia Hematològica i Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain; GRETNHE, Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Montoro J; Servicio de Hematología, Hospital Vall d'Hebrón, Barcelona, Spain.
  • Valcárcel D; Servicio de Hematología, Hospital Vall d'Hebrón, Barcelona, Spain.
  • Pedro C; GRETNHE, Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Servei de Hematologia Clínica, Hospital del Mar, Barcelona, Spain.
  • Sanzo C; Servicio de Hematología, Hospital Central de Asturias, Oviedo, Spain.
  • Luño E; Servicio de Hematología, Hospital Central de Asturias, Oviedo, Spain.
  • Giménez T; Servei d'Hematologia, Hospital Universitari Joan XXIII, Tarragona, Spain.
  • Arnan M; Servei d'Hematologia, Hospital Duran i Reynals, Institut Català d'Oncologia, L'Hospitalet del Llobregat, Spain.
  • Pomares H; Servei d'Hematologia, Hospital Duran i Reynals, Institut Català d'Oncologia, L'Hospitalet del Llobregat, Spain.
  • De Paz R; Servicio de Hematología, Hospital Universitario de La Paz, Madrid, Spain.
  • Arrizabalaga B; Servicio de Hematologia, Hospital Universitario de Cruces, Baracaldo, Spain.
  • Jerez A; Servicio de Hematología, Hospital Morales Meseguer, Murcia, Spain.
  • Martínez AB; Servicio de Hematología, Hospital Morales Meseguer, Murcia, Spain.
  • Sánchez-Castro J; Servei d' Hematologia, Hospital Universitari Arnau de Vilanova, Lleida, Spain.
  • Rodríguez-Gambarte JD; Servicio de Hematología, Hospital Universitario Ramon y Cajal, Madrid, Spain.
  • Raya JM; Servicio de Hematología, Hospital Universitario de Canarias, La Laguna,Tenerife, Spain.
  • Ríos E; Sevicio de Hematologia, Hospital Universitario de Valme, Sevilla, Spain.
  • Rodríguez-Rivera M; Laboratori de Citologia Hematològica i Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain; GRETNHE, Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Espinet B; Laboratori de Citologia Hematològica i Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain; GRETNHE, Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Florensa L; Laboratori de Citologia Hematològica i Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain; GRETNHE, Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
PLoS One ; 10(6): e0129375, 2015.
Article en En | MEDLINE | ID: mdl-26066831
ABSTRACT
Isolated trisomy 8 is not considered presumptive evidence of myelodysplastic syndrome (MDS) in cases without minimal morphological criteria. One reason given is that trisomy 8 (+8) can be found as a constitutional mosaicism (cT8M). We tried to clarify the incidence of cT8M in myeloid neoplasms, specifically in MDS, and the diagnostic value of isolated +8 in MDS. Twenty-two MDS and 10 other myeloid neoplasms carrying +8 were studied. Trisomy 8 was determined in peripheral blood by conventional cytogenetics (CC) and on granulocytes, CD3+ lymphocytes and oral mucosa cells by fluorescence in situ hybridization (FISH). In peripheral blood CC, +8 was seen in 4/32 patients. By FISH, only one patient with chronic myelomonocytic leukemia showed +8 in all cell samples and was interpreted as a cT8M. In our series +8 was acquired in all MDS. Probably, once discarded cT8M by FISH from CD3+ lymphocytes and non-hematological cells, +8 should be considered with enough evidence to MDS.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trisomía / Síndromes Mielodisplásicos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trisomía / Síndromes Mielodisplásicos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article